Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Neurotensin (CAS 39379-15-2): Advancing GPCR and miRNA Re...

    2026-02-05

    Neurotensin (CAS 39379-15-2): Advancing GPCR and miRNA Research Beyond Conventional Boundaries

    Introduction

    Neurotensin (CAS 39379-15-2), a 13-amino acid neuropeptide, has emerged as a pivotal molecular tool for dissecting G protein-coupled receptor (GPCR) signaling and microRNA (miRNA) regulation in both central nervous system and gastrointestinal physiology research. While prior literature has primarily focused on the application of Neurotensin as a potent Neurotensin receptor 1 (NTR1) activator for elucidating GPCR trafficking mechanisms and miRNA dynamics, this article breaks new ground by integrating advanced spectral analysis considerations, comparative methodological insights, and novel experimental frameworks. Our approach is informed by recent advances in fluorescence spectroscopy and machine learning-based signal discrimination, as well as by a rigorous survey of current product-focused and translational resources.

    Mechanism of Action of Neurotensin (CAS 39379-15-2)

    Ligand-Receptor Specificity and Signaling Initiation

    Neurotensin is synthesized as a linear peptide with the sequence Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu, conferring specificity for NTR1, a G protein-coupled receptor highly expressed in the central nervous system and intestinal tissues. Upon ligand binding, NTR1 undergoes conformational changes, activating downstream G protein signaling cascades. This leads to the regulation of diverse physiological processes, including neurotransmission, intestinal motility, and cellular proliferation.

    MicroRNA Modulation and Receptor Trafficking

    Beyond classic second messenger pathways, Neurotensin engagement with NTR1 has been shown to modulate miRNA expression in human colonic epithelial cells, notably inducing upregulation of miR-133α. This miRNA plays a crucial role in controlling receptor recycling by targeting aftiphilin (AFTPH), a key protein in the regulation of endosomal and trans-Golgi network trafficking. These findings underscore the utility of Neurotensin in the study of miRNA regulation in gastrointestinal cells and the elucidation of GPCR trafficking mechanisms.

    Biochemical Properties and Experimental Utility

    The APExBIO Neurotensin (CAS 39379-15-2) reagent is supplied as a highly pure (698%) white lyophilized solid, verified by HPLC and mass spectrometry. Its molecular weight (1672.94) and chemical formula (C78H121N21O20) afford both solubility (≥15.33 mg/mL in DMSO, ≥22.55 mg/mL in water) and stability characteristics ideal for sensitive, reproducible assays. Notably, the product is insoluble in ethanol and requires desiccated storage at -20b0C for optimal integrity. These features support robust experimental design for advanced studies in GPCR and miRNA pathways.

    Integrating Spectral Interference Insights: Lessons from Fluorescence Spectroscopy

    Challenges in High-Fidelity Signal Detection

    While the biological relevance of Neurotensin is well-established, its application in advanced cell signaling studies often relies on fluorescence-based detection methods, which are vulnerable to spectral interference from complex biological matrices. A recent study by Zhang et al. (Molecules 2024, 29, 3132) demonstrated that pollen-derived spectral overlap can significantly confound the classification of hazardous substances, including neuropeptides and toxins, when using excitation–emission matrix fluorescence spectroscopy (EEM).

    Machine Learning-Driven Solutions

    This seminal work applied advanced preprocessing (normalization, multivariate scattering correction, Savitzky–Golay smoothing), spectral transformations (difference, standard normal variable, fast Fourier transform), and random forest classification to effectively eliminate pollen interference, boosting classification accuracy by 9.2%. The implication for GPCR trafficking mechanism studies is profound: by adopting similar preprocessing and classification frameworks, researchers can dramatically enhance the reliability of fluorescence-based assays when investigating Neurotensin-mediated signaling and receptor recycling.

    Deeper Analysis: Neurotensin in Central and Peripheral Systems

    Central Nervous System Neuropeptide Functions

    Neurotensin is not exclusively a gastrointestinal modulator; it functions as a central nervous system neuropeptide, influencing dopaminergic and glutamatergic transmission. By acting as a potent Neurotensin receptor 1 activator, it enables high-resolution mapping of G protein-coupled receptor signaling pathways implicated in neuropsychiatric and neurodegenerative disorders. The peptide's rapid receptor-mediated internalization and recycling, governed by miR-133α/AFTPH axis, offer a unique window into synaptic homeostasis and plasticity.

    Gastrointestinal Physiology Research and Pathology

    In gastrointestinal physiology research, Neurotensin-driven modulation of miRNA and GPCR trafficking impacts epithelial barrier integrity, motility, and inflammatory responses. These pathways are increasingly recognized as therapeutic targets in inflammatory bowel disease, colorectal cancer, and motility disorders. The robust biochemical profile of APExBIO Neurotensin supports its use in dissecting these pathways under physiologically relevant and pathologically altered conditions.

    Comparative Analysis with Alternative Methods

    Beyond Peptide Agonists: Genetic and Small Molecule Tools

    While Neurotensin provides direct and selective activation of NTR1, alternative approaches—such as CRISPR/Cas9-mediated receptor modulation or small-molecule NTR1 agonists—offer complementary but less physiologically faithful models. Genetic manipulation may introduce off-target effects and developmental compensation, while small molecules often lack the precise spatiotemporal resolution of endogenous peptide ligands.

    Advantages of High-Purity, Well-Characterized Reagents

    Compared to traditional peptide preparations, the high purity and batch-to-batch consistency of APExBIO's Neurotensin (B5226) reagent minimize experimental variability and reduce confounding influences in GPCR trafficking mechanism study protocols. The explicit solubility and storage criteria further support reproducible outcomes, a limitation frequently encountered with less rigorously validated products.

    Advanced Applications and Experimental Strategies

    Integrative Use with Spectral Deconvolution Algorithms

    Building on the insights from Zhang et al., researchers can combine Neurotensin-elicited signaling assays with advanced EEM spectral analysis and machine learning-driven classification. This enables the discrimination of true biological signals from environmental or matrix-derived interferences, thus pushing the boundaries of miRNA regulation in gastrointestinal cells and central nervous system studies.

    Future-Ready Workflows for GPCR and miRNA Research

    Emerging experimental strategies include multiplexed live-cell imaging of receptor trafficking, high-throughput miRNA profiling, and real-time kinetic analyses of GPCR internalization. By leveraging APExBIO Neurotensin as a standardized ligand, these approaches can be harmonized across laboratories, facilitating meta-analyses and cross-study validation. This future-oriented perspective distinguishes our approach from previous product-centric guides.

    Intelligent Interlinking: Positioning Within the Current Knowledge Landscape

    Unlike earlier reviews such as "Neurotensin (CAS 39379-15-2): Precision Tool for GPCR Tra...", which emphasize standard workflows and biochemical validation, this article focuses on integrating spectral interference solutions and machine learning insights directly into experimental design. Similarly, while "Neurotensin (CAS 39379-15-2): Unraveling GPCR Trafficking..." explores spectral analysis, our contribution uniquely contextualizes these methods within the framework of interference removal and signal classification, offering a blueprint for next-generation, interference-resilient research workflows. This article thus serves as a strategic bridge between practical protocol guides and the integration of advanced data science in peptide-based signaling studies.

    Conclusion and Future Outlook

    Neurotensin (CAS 39379-15-2) is far more than a classic NTR1 ligand—it is a versatile probe for illuminating the complex interplay between GPCR trafficking, miR-133α modulation, and receptor recycling in both central and peripheral systems. By incorporating recent advances in spectral data preprocessing and machine learning, researchers can overcome the longstanding challenge of environmental interference in fluorescence-based assays. APExBIO’s rigorously validated Neurotensin reagent is thus positioned at the forefront of future-ready biomedical research, empowering the next wave of discoveries in GPCR signaling and miRNA regulation.

    For detailed product information and ordering, visit the APExBIO Neurotensin (CAS 39379-15-2) product page.